Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nithya Krishnan

Showing results (41-50 of 55) with videos related to

Pageof 6
Sort By:
Journal of Immunological Methods|May 2, 2021
Immunoglobulin isotype compositions of ABO specific antibodies are dependent on the individual patient blood group and blood group specificity: Results from a healthy donor cohortSunil Daga, Shimon Hussain, Nithya Krishnan, et al.
Transplantation|March 21, 2009
Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantationRob Higgins, David Lowe, Mark Hathaway, et al.
Transplantation|November 7, 2007
Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibodyRob Higgins, Mark Hathaway, David Lowe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2009
The histological development of acute antibody-mediated rejection in HLA antibody-incompatible renal transplantationRob Higgins, Daniel Zehnder, Klaus Chen, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2010
Double filtration plasmapheresis in antibody-incompatible kidney transplantationRob Higgins, David Lowe, Mark Hathaway, et al.
Transplantation Direct|July 22, 2021
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor TransplantationNithya Krishnan, Aisha Abimbola, Nandhini Machan, et al.
Human Immunology|June 28, 2015
Pregnancy-induced HLA antibodies respond more vigorously after renal transplantation than antibodies induced by prior transplantationRob Higgins, David Lowe, Sunil Daga, et al.
Cell Death and Differentiation|January 30, 2019
Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancerSwathi Ramakrishnan, Victoria Granger, Monika Rak, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2019
TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)Brittany Bunch, Nithya Krishnan, Rebecca D Greenspan, et al.
Molecular Biology of the Cell|August 10, 2012
Quiescent fibroblasts are protected from proteasome inhibition-mediated toxicityAster Legesse-Miller, Irene Raitman, Erin M Haley, et al.
Pageof 6

Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Journal of Immunological Methods|May 2, 2021
Immunoglobulin isotype compositions of ABO specific antibodies are dependent on the individual patient blood group and blood group specificity: Results from a healthy donor cohortSunil Daga, Shimon Hussain, Nithya Krishnan, et al.
Transplantation|March 21, 2009
Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantationRob Higgins, David Lowe, Mark Hathaway, et al.
Transplantation|November 7, 2007
Blood levels of donor-specific human leukocyte antigen antibodies after renal transplantation: resolution of rejection in the presence of circulating donor-specific antibodyRob Higgins, Mark Hathaway, David Lowe, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2009
The histological development of acute antibody-mediated rejection in HLA antibody-incompatible renal transplantationRob Higgins, Daniel Zehnder, Klaus Chen, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 24, 2010
Double filtration plasmapheresis in antibody-incompatible kidney transplantationRob Higgins, David Lowe, Mark Hathaway, et al.
Transplantation Direct|July 22, 2021
HLA Antibody Incompatible Renal Transplantation: Long-term Outcomes Similar to Deceased Donor TransplantationNithya Krishnan, Aisha Abimbola, Nandhini Machan, et al.
Human Immunology|June 28, 2015
Pregnancy-induced HLA antibodies respond more vigorously after renal transplantation than antibodies induced by prior transplantationRob Higgins, David Lowe, Sunil Daga, et al.
Cell Death and Differentiation|January 30, 2019
Inhibition of EZH2 induces NK cell-mediated differentiation and death in muscle-invasive bladder cancerSwathi Ramakrishnan, Victoria Granger, Monika Rak, et al.
Cell Cycle (Georgetown, Tex.)|July 19, 2019
TAp73 expression and P1 promoter methylation, a potential marker for chemoresponsiveness to cisplatin therapy and survival in muscle-invasive bladder cancer (MIBC)Brittany Bunch, Nithya Krishnan, Rebecca D Greenspan, et al.
Molecular Biology of the Cell|August 10, 2012
Quiescent fibroblasts are protected from proteasome inhibition-mediated toxicityAster Legesse-Miller, Irene Raitman, Erin M Haley, et al.
Pageof 6